Serine proteases profiles of Leishmania (Viannia) braziliensis clinical isolates with distinct susceptibilities to antimony

Glucantime (Sb(V)) is the first-line treatment against American Tegumentary Leishmaniasis. Resistance cases to this drug have been reported and related to host characteristics and parasite phenotypes. In this study, 12 Leishmania (Viannia) braziliensis isolates from patients that presented clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zabala-Peñafiel, Anabel, Dias-Lopes, Geovane, Cysne-Finkelstein, Léa, Conceição-Silva, Fátima, Miranda, Luciana de Freitas Campos, Fagundes, Aline, Schubach, Armando de Oliveira, Fernandes Pimentel, Maria Inês, Souza-Silva, Franklin, Machado, Lucas de Almeida, Alves, Carlos Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271011/
https://www.ncbi.nlm.nih.gov/pubmed/34244581
http://dx.doi.org/10.1038/s41598-021-93665-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271011/
https://www.ncbi.nlm.nih.gov/pubmed/34244581
http://dx.doi.org/10.1038/s41598-021-93665-z

Ejemplares similares